1
|
Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med 2021; 25:e00228. [PMID: 34095414 PMCID: PMC8145738 DOI: 10.1016/j.plabm.2021.e00228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Accepted: 04/16/2021] [Indexed: 11/30/2022] Open
Abstract
Objectives In 2009, the Japan Society of Clinical Chemistry (JSCC) recommended a reference method for the measurement of serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels. This automated method uses cholesterol esterase-cholesterol dehydrogenase to measure cholesterol levels in fractions obtained after ultracentrifugation and dextran sulfate/magnesium chloride precipitation. In the present study, using fresh samples, we compared the LDL-C and HDL-C levels measured using this method with those measured using the traditional Centers for Disease Control and Prevention (CDC)-beta-quantification (BQ) method. Design and methods: Using both the JSCC and CDC-BQ methods, LDL-C/HDL-C levels were measured in 47 non-diseased and 126 diseased subjects, whose triglyceride levels were lower than 11.29 mmol/L (1000 mg/dL). Results For LDL-C, the equation of the line representing the correlation between the two methods was y = 0.991x + 0.009 mmol/L; r = 0.999; and Sy/x = 0.025 mmol/L, where x is the mean LDL-C level measured using the CDC-BQ method. Similarly, for HDL-C, the equation of the line representing the correlation between the two methods was y = 0.988x + 0.041 mmol/L, r = 0.999, and Sy/x = 0.019 mmol/L, where x is the mean HDL-C level measured using the CDC-BQ method. Conclusions The JSCC method agreed with the CDC-BQ method in cases of both non-diseased and diseased subjects, including those with dyslipidemia. Using both the JSCC and BQ methods, LDL-C/HDL-C levels were measured. The JSCC method agrees with the BQ method. The JSCC reference method is an accurate, simple, and automatable method. The JSCC method is suitable for quantitative analysis of LDL-C and HDL-C levels.
Collapse
Key Words
- AK, Abell-Kendall
- BFr-C, bottom fraction-cholesterol
- BQ, beta-quantification
- Beta-quantification
- CD, cholesterol dehydrogenase
- CDC, Centers for Disease Control and Prevention
- CHE, cholesterol esterase
- Cholesterol dehydrogenase
- DM, n-dodecyl-β-maltopyranoside
- EDDA, ethylenediamine-N,N′-diacetic acid
- EDTA·2Na, ethylenediamine-N,N′,N′,N′-tetraacetic acid, disodium salt, dihydrate
- HDL-C, high-density lipoprotein-cholesterol
- HDL-cholesterol
- HEPES, 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid
- Homogeneous assay
- LB, Liebermann-Burchard
- LDL-C, low-density lipoprotein-cholesterol
- LDL-cholesterol
- NIST, National Institute of Standards and Technology
- Reference method
- SRM, Standard Reference Material
- Syx, standard deviation of the regression line
- TC, total cholesterol
- TG, triglycerides
- apo, apolipoprotein
Collapse
Affiliation(s)
- Yuzo Kayamori
- Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka City, Fukuoka, 812-8582, Japan
| | - Masakazu Nakamura
- Department of Preventive Cardiology, Lipid Reference Laboratory, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan (retired in 2018)
| | - Koji Kishi
- Bio-Reagent Material Development, Bio-Diagnostic Reagent Technology Center, Sysmex Corporation, 1-1-2, Murotani, Nishi-ku, Kobe, 651-2241, Japan
| | - Takashi Miida
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
| | - Kunihiro Nishimura
- Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan
| | - Tomonori Okamura
- Department of Preventive Medicine and Public Health, Keio University Graduate School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
| | - Satoshi Hirayama
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
| | - Hirotoshi Ohmura
- Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
| | - Hiroshi Yoshida
- Department of Laboratory Medicine, The Jikei University Kashiwa Hospital, 161-1 Kashiwashita, Kashiwa City, Ciba, 277-8567, Japan
| | - Masumi Ai
- Tokyo Medical and Dental University, Medical Hospital, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan
| | - Akira Tanaka
- Nutrition Clinic, Kagawa Nutrition University, 3-9-21 Chiyoda, Sakado City, Saitama, 350-0288, Japan
| | - Hiroyuki Sumino
- Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan
| | - Masami Murakami
- Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan
| | - Ikuo Inoue
- Department of Endocrinology and Diabetes, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan
| | - Tamio Teramoto
- Teikyo Academic Research Center, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan
| | - Shinji Yokoyama
- Department of Food and Nutritional Sciences, Practice Center for Registered Dietitian, Chubu University, 1200 Matsumoto-cho, Kasugai, Aichi, 487-8501, Japan
| |
Collapse
|
2
|
Chmayssem A, Monsalve-Grijalba K, Alias M, Mourier V, Vignoud S, Scomazzon L, Muller C, Barthes J, Vrana NE, Mailley P. Reference method for off-line analysis of nitrogen oxides in cell culture media by an ozone-based chemiluminescence detector. Anal Bioanal Chem 2021; 413:1383-1393. [PMID: 33404746 DOI: 10.1007/s00216-020-03102-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 11/25/2020] [Accepted: 11/26/2020] [Indexed: 11/28/2022]
Abstract
Nitric oxide (NO) and its by-products are important biological signals in human physiology and pathology particularly in the vascular and immune systems. Thus, in situ determination of the NO-related molecule (NOx) levels using embedded sensors is of high importance particularly in the context of cellular biocompatibility testing. However, NOx analytical reference method dedicated to the evaluation of biomaterial biocompatibility testing is lacking. Herein, we demonstrate a PAPA-NONOate-based reference method for the calibration of NOx sensors. After, the validation of this reference method and its potentialities were demonstrated for the detection of the oxidative stress-related NO secretion of vascular endothelial cells in a 3D tissue issued from 3D printing. Such NOx detection method can be an integral part of cell response to biomaterials. Graphical abstract.
Collapse
Affiliation(s)
- Ayman Chmayssem
- Univ. Grenoble Alpes, CEA, LETI, DTBS, L2CB, Grenoble, F-38000, France.
| | | | - Mélanie Alias
- Univ. Grenoble Alpes, CEA, LETI, DTBS, L2CB, Grenoble, F-38000, France
| | - Véronique Mourier
- Univ. Grenoble Alpes, CEA, LETI, DTBS, L2CB, Grenoble, F-38000, France
| | - Séverine Vignoud
- Univ. Grenoble Alpes, CEA, LETI, DTBS, L2CB, Grenoble, F-38000, France
| | - Loïc Scomazzon
- Inserm UMR 1121, 11 rue Humann, 67085, Strasbourg, France
| | - Céline Muller
- Inserm UMR 1121, 11 rue Humann, 67085, Strasbourg, France
| | - Julien Barthes
- Inserm UMR 1121, 11 rue Humann, 67085, Strasbourg, France
| | - Nihal Engin Vrana
- Spartha Medical, 14B Rue de la Canardière, 67100, Strasbourg, France
| | - Pascal Mailley
- Univ. Grenoble Alpes, CEA, LETI, DTBS, L2CB, Grenoble, F-38000, France.
| |
Collapse
|
3
|
Parisio EM, Camarlinghi G, Coppi M, Niccolai C, Antonelli A, Nardone M, Vettori C, Giani T, Mattei R, Rossolini GM. Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa. Clin Microbiol Infect 2020; 27:S1198-743X(20)30725-4. [PMID: 33285277 DOI: 10.1016/j.cmi.2020.11.029] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 11/16/2020] [Accepted: 11/27/2020] [Indexed: 11/16/2022]
Abstract
OBJECTIVES To compare fosfomycin susceptibility testing with the commercial agar dilution (AD) test, AD Fosfomycin (Liofilchem, Roseto degli Abruzzi, Italy) and the reference AD method, using a collection of multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa clinical isolates. METHODS The collection included 119 carbapenemase-producing Enterobacterales, 53 Enterobacterales producing acquired AmpC-type and/or extended-spectrum β-lactamases and 38 carbapenemase-producing P. aeruginosa, including representatives of different high-risk clones. AD Fosfomycin and AD reference method (ISO 20776-1:2019) were performed starting from the same microbial suspension. Results were interpreted according to EUCAST clinical breakpoints (10.0). Essential agreement (EA), category agreement (CA) and error rates were calculated as described by the International Organization for Standardization. RESULTS Of 172 Enterobacterales, 143 (83.1%, including 92.9% (52 of 56) of the NDM-producers and 84.2% (48 of 57) of the KPC-producers) were susceptible to fosfomycin using reference AD. A CA of 91.9% (158 of 172; 95% CI 87.1%-95.3%) and an EA of 92.5% (136 of 147; 95% CI 87.4%-96.0%), respectively, were calculated for the commercial AD Fosfomycin test, with 9.8% (14 of 128) of major errors and no very major errors (0 of 29). Overall, 86.8% (33 of 38) of P. aeruginosa showed a fosfomycin MIC ≤128 mg/L using reference AD. An EA of 84.8% (95% CI 66.3%-92.0%) was calculated for the commercial AD Fosfomycin test, with a CA of 100% (95% CI 93.6%-100%) when considering a tentative breakpoint at 128 mg/L. CONCLUSIONS AD Fosfomycin showed an overall good concordance compared with reference AD.
Collapse
Affiliation(s)
- Eva Maria Parisio
- Clinical Chemistry and Microbiology Analysis Unit, San Luca Hospital, USL Toscana Nord Ovest, Lucca, Italy
| | - Giulio Camarlinghi
- Clinical Chemistry and Microbiology Analysis Unit, San Luca Hospital, USL Toscana Nord Ovest, Lucca, Italy
| | - Marco Coppi
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
| | - Claudia Niccolai
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - Alberto Antonelli
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
| | - Maria Nardone
- Clinical Chemistry and Microbiology Analysis Unit, San Luca Hospital, USL Toscana Nord Ovest, Lucca, Italy
| | - Chiara Vettori
- Clinical Chemistry and Microbiology Analysis Unit, San Luca Hospital, USL Toscana Nord Ovest, Lucca, Italy
| | - Tommaso Giani
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
| | - Romano Mattei
- Clinical Chemistry and Microbiology Analysis Unit, San Luca Hospital, USL Toscana Nord Ovest, Lucca, Italy
| | - Gian Maria Rossolini
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
| |
Collapse
|
4
|
Schön T, Werngren J, Machado D, Borroni E, Wijkander M, Lina G, Mouton J, Matuschek E, Kahlmeter G, Giske C, Santin M, Cirillo DM, Viveiros M, Cambau E. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis. Clin Microbiol Infect 2020; 27:288.e1-288.e4. [PMID: 33198949 DOI: 10.1016/j.cmi.2020.10.019] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 10/14/2020] [Accepted: 10/19/2020] [Indexed: 11/30/2022]
Abstract
OBJECTIVES The first objective of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) subcommittee for antimycobacterial susceptibility testing (AMST), launched in 2016, was to set a reference method for determining the MICs of antituberculous agents, since many protocols are used worldwide and a consensus one is needed for the determination of microbiological breakpoints. METHODS During 2017 and 2018, MIC determination protocols were evaluated prospectively in a multicentre study within the four AMST laboratories. MIC results were obtained for isoniazid, levofloxacin and amikacin on the reference strain Mycobacterium tuberculosis H37Rv ATCC 27294. Broth microdilution (BMD) in Middlebrook 7H9 and solid medium dilution (SMD) in Middlebrook 7H10 were performed using two inoculum concentrations. MICs were interpreted with regard to visual and 99% inhibition after 7, 14 or 21 days of incubation for BMD and 21 days for SMD. RESULTS Following the EUCAST reference protocol, intra- and inter-assay agreements were within ±1 MIC dilution for >95% of the observations for the three drugs in both methods. MIC values, presented as MIC mode (range) for BMD and SMD respectively, were: 0.03 (0.015-0.06) mg/L and 0.12 (0.06-0.25) mg/L for isoniazid, 0.25 mg/L (0.25-0.5) and 0.5 mg/L (0.12-0.5) for levofloxacin, and 0.5 mg/L (0.5-1.0) and 0.5 mg/L (0.5-1.0) for amikacin. CONCLUSIONS Both SMD and BMD were reproducible and eligible as a reference method for MIC determination of the Mycobacterium tuberculosis complex (MTBC). BMD was finally selected as the EUCAST reference method. From now on it will be used to set epidemiological cut-off values and clinical breakpoints of new and old antituberculous agents.
Collapse
Affiliation(s)
- Thomas Schön
- Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Linköping University, Sweden
| | - Jim Werngren
- Public Health Agency of Sweden, Department of Microbiology, Unit of Laboratory Surveillance of Bacterial Pathogens, 171 82 Solna, Sweden
| | - Diana Machado
- Unit of Medical Microbiology of the Instituto de Higiene e Medicina Tropical and Global Health and Tropical Medicine from Universidade NOVA de Lisboa, P-1349-008 Lisboa, Portugal
| | - Emanuele Borroni
- Emerging Bacterial Pathogen, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
| | - Maria Wijkander
- Public Health Agency of Sweden, Department of Microbiology, Unit of Laboratory Surveillance of Bacterial Pathogens, 171 82 Solna, Sweden
| | - Gerard Lina
- CIRI, Centre International de Recherche en Infectiologie, Université Lyon 1, Ecole Normale Supérieure de Lyon, and Centre National de Référence des Staphylocoques, Institut des Agent Infectieux, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
| | - Johan Mouton
- Department of Medical Microbiology and Infectious Diseases, Research and Development Unit, Erasmus Medical Centre, Rotterdam, the Netherlands
| | - Erika Matuschek
- Department of Clinical Microbiology, Central Hospital, and EUCAST Development Laboratory, Växjö, Sweden
| | - Gunnar Kahlmeter
- Department of Clinical Microbiology, Central Hospital, and EUCAST Development Laboratory, Växjö, Sweden
| | - Christian Giske
- Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
| | - Miguel Santin
- Department of Infectious Diseases, Bellvitge University Hospital-IDIBELL, University of Barcelona, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
| | - Daniela Maria Cirillo
- Emerging Bacterial Pathogen, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
| | - Miguel Viveiros
- Unit of Medical Microbiology of the Instituto de Higiene e Medicina Tropical and Global Health and Tropical Medicine from Universidade NOVA de Lisboa, P-1349-008 Lisboa, Portugal
| | - Emmanuelle Cambau
- APHP-GHU Nord, Mycobactériologie Spécialisée et de Référence, Laboratoire Associé du Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), and Université de Paris, INSERM, IAME UMR1137, F-75006 Paris, France.
| |
Collapse
|
5
|
Schön T, Werngren J, Machado D, Borroni E, Wijkander M, Lina G, Mouton J, Matuschek E, Kahlmeter G, Giske C, Santin M, Cirillo DM, Viveiros M, Cambau E. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination. Clin Microbiol Infect 2020; 26:1488-92. [PMID: 32750539 DOI: 10.1016/j.cmi.2020.07.036] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Revised: 06/29/2020] [Accepted: 07/01/2020] [Indexed: 02/03/2023]
Abstract
SCOPE Several methods are used worldwide for antibiotic susceptibility testing (AST) for the Mycobacterium tuberculosis complex (MTBC). The variability in the results obtained with these methods hampers setting epidemiological cut-off (ECOFF) values and clinical breakpoints according to EUCAST guidelines. Methods for susceptibility testing and determination of the minimal inhibitory concentrations (MICs) need to be standardized for MTBC isolates for old and new agents. Our objective was to establish a standardized reference method for MIC determination for MTBC. METHODS The EUCAST antimycobacterial susceptibility testing subcommittee (AMST) compared protocols of MIC determination with regard to medium, inoculum preparation, antituberculous agent preparation, incubation, reading of the results and interpretation. RECOMMENDATIONS The EUCAST reference method of MIC determination for MTBC is the broth microdilution method in Middlebrook 7H9-10% OADC medium. The final inoculum is a 105 CFU/mL suspension, obtained from a 10-2 dilution of a 0.5 McFarland suspension prepared after vortexing bacterial colonies with glass beads before suspending them in sterile water. The culture is maintained in a U-shaped 96-well polystyrene microtitre sterile plate with a lid incubated at 36° ± 1°C. Reading is done using an inverted mirror as soon as the 1:100 diluted control (i.e. 103 CFU/mL suspension) shows visual growth. The MIC, expressed in mg/L, is the lowest concentration that inhibits visual growth. Mycobacterium tuberculosis H37Rv ATCC 27294 is used as the reference strain and its targeted MIC values are within the range 0.03-0.12 for isoniazid, 0.12-0.5 for levofloxacin and 0.25-1 mg/L for amikacin. CONCLUSIONS The EUCAST reference method for MTBC was endorsed by EUCAST after public consultation and will from now on be used to define EUCAST ECOFFs and clinical breakpoints. This reference method is not primarily intended to be used under routine conditions and the AST methods will need to be calibrated against this reference method to be used with EUCAST breakpoints.
Collapse
|
6
|
Romero Y, Velásquez RMA, Noel J. Development of a multiple regression model to calibrate a low-cost sensor considering reference measurements and meteorological parameters. Environ Monit Assess 2020; 192:498. [PMID: 32648052 DOI: 10.1007/s10661-020-08440-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 06/21/2020] [Indexed: 06/11/2023]
Abstract
Low-cost air quality sensors are widely used to improve temporal and spatial resolution of air quality data. In Lima, Peru, only a limited number of reference air quality monitors have been installed, which has led to a lack of data for establishing environmental and health policies. Low-cost technology is promising for developing countries because it is small and inexpensive to operate and maintain. However, considerable work remains to be done to improve data quality. In this study, a low-cost sensor was installed with a reference monitor station as the first stage for the calibration process, and a multiple regression model was developed based on reference measurements as an outcome variable using sensor data, temperature, and relative humidity as the predictive parameters. The results show that this particular technology exhibits a promising performance in measuring PM2.5 and PM10 (particulate matter with diameter aerodynamic less than 2.5 μm and 10 μm, respectively); however, the correlation for PM2.5 appears to be better. Temperature and relative humidity data from the sensor were only partially analyzed due to the evident low correlation with the reference meteorological data. The objective of this study is to begin analyzing the performance of low-cost sensors that have already been introduced to the Peruvian market and selecting those that perform better to provide for informed decision-making.
Collapse
Affiliation(s)
- Yovitza Romero
- Energy Engineering Department, Universidad de Ingenieria y Tecnologia - UTEC, Lima, Peru.
| | | | - Julien Noel
- Energy Engineering Department, Universidad de Ingenieria y Tecnologia - UTEC, Lima, Peru
| |
Collapse
|
7
|
Frank C, Brauckmann C, Palos M, Arsene CG, Neukammer J, Del Castillo Busto ME, Zakel S, Swart C, Güttler B, Stosch R. Comparison of potential higher order reference methods for total haemoglobin quantification-an interlaboratory study. Anal Bioanal Chem 2017; 409:2341-2351. [PMID: 28091714 DOI: 10.1007/s00216-016-0176-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 12/14/2016] [Accepted: 12/21/2016] [Indexed: 12/27/2022]
Abstract
The total haemoglobin (Hb) concentration in blood is one of the most frequently measured analytes in clinical medicine because of its significance for evaluating the health state of a human. The spectrophotometric cyanmethaemoglobin (HiCN) method is the internationally accepted conventional reference method to determine this biomarker. It is frequently used in clinical routine diagnostics but is not traceable to the International System of Units and thus does not meet highest metrological demands. A further critical issue is the toxicity of the necessary potassium cyanide. Different methods to solve these problems are reported here. They all were validated against the HiCN method in an interlaboratory comparison by measuring the total Hb concentration present in the certified reference material JCCRM 912-2M. Methods considered were the spectrophotometric alkaline haematin detergent (AHD) method as well as several isotope dilution (ID)-based approaches. The latter include inductively coupled plasma mass spectrometry (ICP-MS), species-specific (SS) ICP-MS, organic MS and Raman spectrometry. Graphical abstract ᅟ.
Collapse
Affiliation(s)
- Claudia Frank
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany.
| | - Christine Brauckmann
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| | - Marie Palos
- Laboratoire National de Métrologie et d'essais (LNE), 1, Rue Gaston Boissier, 75784, Paris Cedex 15, France
| | - Cristian G Arsene
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| | - Joerg Neukammer
- Physikalisch-Technische Bundesanstalt (PTB), Abbestraße 2-12, 10587, Berlin, Germany
| | | | - Sabine Zakel
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| | - Claudia Swart
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| | - Bernd Güttler
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| | - Rainer Stosch
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116, Braunschweig, Germany
| |
Collapse
|